SIU 2020 GU Malignancies - Prostate

Viewing 1-15 of 15 articles

SIU Virtual Congress 2020: Germline and Somatic Mutations in Advanced Prostate Cancer: Actionable Targets

SIU Virtual Congress 2020: Liquid Biopsy in Prostate Cancer, Where are We Now?

SIU Virtual Congress 2020: Advantages and Limitations of PSMA-PET

SIU Virtual Congress 2020: Is Serum PSA Still a Standard Marker for Prostate Cancer: Do We Have Game Changers?

SIU Virtual Congress 2020: The Role of Genomic Testing in Prostate Cancer

SIU Virtual Congress 2020: Genetic Counseling in Prostate Cancer

SIU Virtual Congress 2020: DNA Repair Gene Mutations and PARP Inhibitors in Prostate Cancer

SIU Virtual Congress 2020: Is Lymphadenectomy Necessary in Prostate Cancer? - Pros and Cons

SIU Virtual Congress 2020: Should mpMRI be the Male Mammogram?

SIU Virtual Congress 2020: Canadian Urological Association Lecture: The Current and Future State of Robotics in Oncology

SIU Virtual Congress 2020: Management of Non-Metastatic CRPC: Lessons from Recent Landscape Trials

SIU Virtual Congress 2020: Debate: Management of the Metastases in Oligometastatic Prostate Cancer - The Metastases Should be Treated with Best Systemic Therapy Alone

SIU Virtual Congress 2020: Debate: Management of the Metastases in Oligometastatic Prostate Cancer - The Metastases Should be Treated with Metastasis-Directed Therapy

SIU Virtual Congress 2020: Debate: Imaging in the Definition of Oligometastatic Prostate Cancer - Oligometastatic Disease Should be Defined Based on Novel Imaging Modalities

SIU Virtual Congress 2020: Debate: Imaging in the Definition of Oligometastatic Prostate Cancer - Oligometastatic Disease Should be Defined Based on Standard Imaging Modalities